In India, cancer of the cervix uteri is the 3rd most common cancer with an Incidence rate of 18.3% (123,907 cases) and the second leading cause of death with a mortality rate of 9.1% as per GLOBOCAN 2020. The Age standardized incidence rate per 100 000 population was 18 while the 5-year prevalence rate across all ages was 42.82 per 1 lakh population. India accounts for the highest number of cervical cancer cases in Asia, followed by China, according to a latest Lancet study on the disease.

The high occurrence of cervical cancer and related deaths in India is attributed to poor screening, low awareness, social inequality, stigma, and poverty. Cervical cancer awareness in the Indian community has been alarmingly low over the years despite the country having a high disease burden. Most people are not aware of the fact that it is preventable with timely vaccination and screening protocols.

Given FPA India's focus, and reach across 18 states and 40 branches, FPA India is best suited to engage with communities for the prevention of cervical cancer. FPA India will focus on prevention strategies -promotion of HPV vaccination among adolescents and screening of women for cervical cancer along with treatment of precancerous lesions. In case of diagnosis, FPA India will have a strong referral and follow up strategy for treatment. 

In association with the TATA Mumbai Marathon, FPA India plans to raise 1 crore for the campaign 'RACE TO ERASE CERVICAL CANCER' . Through this campaign, FPA India will address with 20,000 women and girls and aim to implement a 5-pronged intervention:

awareness of cervical cancer

prevention through HPV vaccine

screening for cervical cancer

treatment of precancerous lesions

referral for cancer treatment if diagnosed.    

Be a part of this urgent mission!

Join us to make a real difference. Your donation helps us save India's daughters. Act now to protect their futures.